These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8926011)

  • 1. Decreased Na/K ATPase ouabain binding sites in red blood cells of patients with insulin-dependent diabetes and healthy north African control subjects: relationship with diabetic neuropathy.
    Raccah D; Dadoun F; Coste T; Vague P
    Horm Metab Res; 1996 Mar; 28(3):128-32. PubMed ID: 8926011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
    Raccah D; Gallice P; Pouget J; Vague P
    Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients.
    Jannot MF; Raccah D; De La Tour DD; Coste T; Vague P
    Metabolism; 2002 Mar; 51(3):284-91. PubMed ID: 11887161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of diabetic neuropathy with Na/K ATPase gene polymorphism.
    Vague P; Dufayet D; Coste T; Moriscot C; Jannot MF; Raccah D
    Diabetologia; 1997 May; 40(5):506-11. PubMed ID: 9165217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic factors, Na K ATPase activity and neuropathy in diabetics].
    Vague P; Dufayet D; Lamotte MF; Mouchot C; Raccah D
    Bull Acad Natl Med; 1997 Dec; 181(9):1811-21; discussion 1821-3. PubMed ID: 9611401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between red blood cell Na/K-ATPase activities and diabetic complications in patients with type 2 diabetes mellitus.
    Koc B; Erten V; Yilmaz MI; Sonmez A; Kocar IH
    Endocrine; 2003 Aug; 21(3):273-8. PubMed ID: 14515013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between neuropathy, hypertension and red blood cell Na/K ATPase in patients with insulin-dependent diabetes mellitus.
    Jannot MF; Raccah D; Dufayet de la Tour D; Coste T; Gouvernet J; Vague P
    Diabetes Metab; 1999 Mar; 25(1):35-42. PubMed ID: 10335422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
    Ottlecz A; Bensaoula T
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Na,K-adenosine triphosphatase (ATPase) concentration and Na,K-ATPase-dependent adenosine triphosphate turnover in human erythrocytes in diabetes.
    Garner MH
    Metabolism; 1996 Aug; 45(8):927-34. PubMed ID: 8769346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in retinal Na+, K(+)-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats.
    Ottlecz A; Garcia CA; Eichberg J; Fox DA
    Curr Eye Res; 1993 Dec; 12(12):1111-21. PubMed ID: 8137634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifications induced by plasma from insulin-dependent diabetic patients and by lysophosphatidylcholine on human Na+,K(+)-adenosine triphosphatase.
    Rabini RA; Fumelli P; Zolese G; Amler E; Salvolini E; Staffolani R; Cester N; Mazzanti L
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2405-10. PubMed ID: 9661619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients.
    Raccah D; Fabreguetts C; Azulay JP; Vague P
    Diabetes Care; 1996 Jun; 19(6):564-8. PubMed ID: 8725852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma.
    Finotti P; Palatini P
    Diabetologia; 1986 Sep; 29(9):623-8. PubMed ID: 3025045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation defect of sodium pump evidenced in diabetic patients by a microcalorimetric study.
    Issautier T; Kovacic H; Gallice P; Raccah D; Vague P; Crevat A
    Clin Chim Acta; 1994 Aug; 228(2):161-70. PubMed ID: 7988032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of Na,K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids.
    Gerbi A; Maixent JM; Barbey O; Jamme I; Pierlovisi M; Coste T; Pieroni G; Nouvelot A; Vague P; Raccah D
    J Neurochem; 1998 Aug; 71(2):732-40. PubMed ID: 9681464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level.
    De La Tour DD; Raccah D; Jannot MF; Coste T; Rougerie C; Vague P
    Diabetologia; 1998 Sep; 41(9):1080-4. PubMed ID: 9754827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of nerve Na+,K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy.
    Scarpini E; Bianchi R; Moggio M; Sciacco M; Fiori MG; Scarlato G
    J Neurol Sci; 1993 Dec; 120(2):159-67. PubMed ID: 8138805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
    Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
    Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Na+/K(+)-ATPase activity in vascular smooth muscle from streptozotocin diabetic rat.
    Smith JM; Paulson DJ; Solar SM
    Cardiovasc Res; 1997 Apr; 34(1):137-44. PubMed ID: 9217883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.